Roger Ver Pardon Odds Increase Following Trump’s Crypto Pardons
- Ver’s pardon odds surpass 20% on key markets.
- Post-CZ pardon speculation could drive decisions.
- No immediate BTC or BCH impact noted.
The odds of Roger Ver receiving a pardon from Donald Trump have surged to 15–20% on prediction markets. This spike follows Trump’s pardon of crypto figure CZ, sparking speculation on clemency for other prominent figures like Ver.
Ver’s pardon odds increased due to Trump’s recent actions favoring crypto figures. The crypto community anticipates potential clemency, impacting market predictions and investor sentiment.
Background
Roger Ver, known as “Bitcoin Jesus,” has recently settled his U.S. tax liabilities for approximately $50 million. His pardon odds surged on major prediction markets after the Trump administration extended clemency to Changpeng Zhao.
Ver, a former U.S. citizen turned Bitcoin evangelist, remains central in the Bitcoin Cash ecosystem. Trump’s decision to pardon Zhao sends a pro-crypto signal, prompting speculation of potential relief for Ver and others.
Polymarket data shows trading volumes for Ver’s pardon reaching over $550,000. Despite this, no significant market changes have been observed in Bitcoin or Bitcoin Cash prices, but investor sentiment in crypto tax compliance is highly active.
“The market potential for presidential pardons is influencing predictions. Financial analysts note the impact of celebrity clemency on crypto sector perceptions, although no immediate asset value changes are evident,” said Jake Chervinsky, Chief Legal Officer at Variant Fund. Source .
Ver’s case resolution and Trump’s current stance could lead to relaxed crypto taxation policies. Analysts emphasize the significance of such actions in shaping future market expectations and regulatory landscapes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins
Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.
STONK hits new highs after erasing 27% crash
25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
Crypto prices
More
